MD1780G2 - Metodă de tratament al pacienţilor cu ciroze hepatice - Google Patents
Metodă de tratament al pacienţilor cu ciroze hepatice Download PDFInfo
- Publication number
- MD1780G2 MD1780G2 MDA20010032A MD20010032A MD1780G2 MD 1780 G2 MD1780 G2 MD 1780G2 MD A20010032 A MDA20010032 A MD A20010032A MD 20010032 A MD20010032 A MD 20010032A MD 1780 G2 MD1780 G2 MD 1780G2
- Authority
- MD
- Moldova
- Prior art keywords
- patients
- hepatic cirrhosis
- treatment
- hepatoprotectors
- losartan
- Prior art date
Links
- 208000019425 cirrhosis of liver Diseases 0.000 title abstract 2
- 239000002083 C09CA01 - Losartan Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- KJJZZJSZUJXYEA-UHFFFAOYSA-N losartan Chemical compound CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C=2[N]N=NN=2)C=C1 KJJZZJSZUJXYEA-UHFFFAOYSA-N 0.000 abstract 1
- 229960004773 losartan Drugs 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Invenţia se referă la medicină, şi anume la hepatologie.Esenţa invenţiei constă în aceea că pacienţilor cu ciroze hepatice concomitent cu administrarea hepatoprotectoarelor şi vitaminelor suplimentar timp de 27…35 zile se administrează losartan câte 0,0125…0,025 g o dată pe zi per os.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20010032A MD1780G2 (ro) | 2001-02-02 | 2001-02-02 | Metodă de tratament al pacienţilor cu ciroze hepatice |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20010032A MD1780G2 (ro) | 2001-02-02 | 2001-02-02 | Metodă de tratament al pacienţilor cu ciroze hepatice |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD1780F1 MD1780F1 (ro) | 2001-11-30 |
| MD1780G2 true MD1780G2 (ro) | 2002-05-31 |
Family
ID=19739746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20010032A MD1780G2 (ro) | 2001-02-02 | 2001-02-02 | Metodă de tratament al pacienţilor cu ciroze hepatice |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD1780G2 (ro) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD4458C1 (ro) * | 2014-06-19 | 2017-08-31 | Мария ДАНУ | Utilizarea preparatului Polibiolină în tratamentul bolnavilor cu ciroză hepatică |
-
2001
- 2001-02-02 MD MDA20010032A patent/MD1780G2/ro unknown
Non-Patent Citations (2)
| Title |
|---|
| Lebrec D. et al. A randomized controller study of propranolol for prevention of recurrent gastruintestinal bleeding in patients with cirrhosis: a final report. Hepatology, 1984, vol. 4, p. 355-358 * |
| Ohnishi A. et al. Kinetics and dynamics of enalapril in patients with liver cirrhosis. Clinical Pharmacology and Therapeutics, 1989, vol. 45, p. 657-665 * |
Also Published As
| Publication number | Publication date |
|---|---|
| MD1780F1 (ro) | 2001-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL135335A0 (en) | Method for inhibiting or preventing hormone induced adverse effects and novel pharmaceutical compositions comprising carotenoids | |
| WO2006008639A8 (en) | Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody | |
| DK0502092T3 (da) | Oralt præparat til behandling af inflammatoriske tarmsygdomme | |
| IL175158A0 (en) | Tocopherol-modified therapeutic drug compounds | |
| DE69831869D1 (de) | Verbesserte verabreichungstechnik für multiple medikamentengaben | |
| MXPA03006217A (es) | Sistema de administracion espaciada de farmacos. | |
| CY1105707T1 (el) | Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου | |
| ATE298324T1 (de) | Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel | |
| MD2549F1 (ro) | Metoda de tratament al hepatitei virale cronice C | |
| MD990258A (ro) | Metoda de tratament al hepatitei virale acute B | |
| MXPA04001912A (es) | Aminobenzofenonas novedosas. | |
| AR048318A1 (es) | Formulaciones de matriz orales que comprenden licarbazepina | |
| MXPA01012936A (es) | Composicion farmaceutica que contiene sibutramina y orlistat. | |
| MD1780G2 (ro) | Metodă de tratament al pacienţilor cu ciroze hepatice | |
| SE9800905D0 (sv) | New therapy in glomerulonephritis | |
| BG105434A (bg) | Сертралинов орален концентрат | |
| GB0018322D0 (en) | Pharmaceutical compositions | |
| AR109456A2 (es) | Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación | |
| IL164763A0 (en) | Byperforin derivatives, the use thereof and formulations containing them | |
| TW200501967A (en) | Nemorubicin for use in the preparation of a medicament for liver disease | |
| MD1609F1 (ro) | Metoda de tratament al stomatitei aftoase recidivante cronice | |
| MD1610G2 (ro) | Metodă de tratament al stomatitei aftoase recidivante cronice | |
| MD3381G2 (ro) | Metodă de tratament al parotiditei cronice la copii | |
| WO2003066806A3 (en) | Therapeutic use of aziridino compounds | |
| MD2068G2 (ro) | Metodă de tratament al infecţiei cu Herpes simplex |